Zobrazeno 1 - 10 of 43 pro vyhledávání: '"S. Zaun"'
1
Antiandrogene Therapie beim nicht-metastasierten Prostatakarzinom: Eine Auswertung von über 900 Erfahrungsberichten
Autor: B. J. Schmitz-Dräger, S. Zaun
Publikováno v: TumorDiagnostik & Therapie. 36:277-282
Hintergrund: Neben Beobachtung, Operation und Bestrahlung stellt die Hormontherapie – adjuvant bzw. in bestimmten Situationen primar eingesetzt – eine wesentliche Therapieoption des nicht metastasierten Prostatakarzinoms dar. In mehreren randomis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::133c68389d30125c62167fc904a95e32
https://doi.org/10.1055/s-0035-1553394
Zobrazit plný text záznamu
2
EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Autor: Joerg Mezger, S Zaun, Wilfried Eberhardt, Juergen R. Fischer, Peter Schirmacher, Manfred Dietel, Monika Serke, Wolfgang Schuette, Michael Thomas, J.-Matthias Graf von der Schulenburg, Christian Schumann
Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 24:1254-1261
Introduction: EGFR mutations confer sensitivity to EGFR tyrosine kinase inhibitors (TKI) in advanced non–small cell lung cancer (NSCLC). We investigated the clinicopathologic characteristics associated with EGFR mutations and their impact on real-w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5a4572023ba3b4a0435a5bda1d58dc
https://doi.org/10.1158/1055-9965.epi-14-1149
Zobrazit plný text záznamu
3
Abstract P6-09-08: COMPliance and Arthralgia in Clinical Therapy: The COMPACT trial, assessing the incidence of arthralgia, therapy costs and compliance within the first year of adjuvant anastrozole therapy
Autor: S Zaun, Maria Blettner, R. Kreienberg, C. Jackisch, Peter S. Klein, Winfried Rief, Nadia Harbeck, P. Hadji, WW Bolten, Diethelm Wallwiener, K König, H. J. Hindenburg
Publikováno v: Cancer Research. 72:P6-09
Background: Aromatase Inhibitors (AI) are well established as adjuvant treatment for postmenopausal (PMP) women with hormone receptor positive (HR+) early breast cancer (EBC). However, phase III clinical trials have reported higher rates of arthralgi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5dbd9845d0bfad942595cac643249ec3
https://doi.org/10.1158/0008-5472.sabcs12-p6-09-08
Zobrazit plný text záznamu
6
Aromatasehemmer-assoziierte Arthralgien: klinische Erfahrungen und Therapieempfehlungen
Autor: Nicolai Maass, S Zaun, WW Bolten, P. Hadji, C. Jackisch
Publikováno v: Geburtshilfe und Frauenheilkunde. 68:977-985
OBJECTIVE: It is well documented that aromatase inhibitors (AI) are superior to tamoxifen as an adjuvant endocrine therapy in postmenopausal women with hormone receptor-positive breast cancer. However, compared with tamoxifen, an elevated incidence o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9693948458f7ee432a3a042fb8ac0c9f
https://doi.org/10.1055/s-2008-1038945
Zobrazit plný text záznamu
7
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
Autor: WW Bolten, C. Jackisch, H. J. Hindenburg, S Zaun, P. Hadji, Maria Blettner, D. Wallwiener, Peter S. Klein, K König, Winfried Rief, R. Kreienberg, Nadia Harbeck
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 25(2)
5 Office-based Professional Association Gynecologic Oncologists e.V. in Germany (BNGO e.V.), Berlin; 6 Background: This prospective study evaluated the relationship between arthralgia and compliance during the first year of adjuvant anastrozole thera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b57b7f4a445a41bd82331014d26ef8
https://pubmed.ncbi.nlm.nih.gov/24355487
Zobrazit plný text záznamu
9
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer
Autor: R. Kreienberg, P. Hadji, C Windemuth-Kieselbach, S Zaun, Nadia Harbeck, Maria Blettner, C. Jackisch, H.-J. Lück
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 24(6)
BACKGROUND Compliance and persistence are often overlooked in adjuvant breast cancer treatment. PATIENTS AND METHODS PACT was a prospective, multicenter, randomized, open, parallel-group study assessing whether educational materials (EMs) enhanced co
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71e99f6437280375d33094078e68f41
https://pubmed.ncbi.nlm.nih.gov/23378537
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje